修补血液:优化血液凝固系统,用于治疗目的
Eduardo Anitua1,2,3, Sabino Padilla1,2,3
1Eduardo Anitua Foundation for Biomedical Research, 01007 Vitoria, Spain.
Bioengineering (Basel, Switzerland)
|December 30, 2025
概括
富血小板血 (PRP) 疗法利用血液中的生长因子进行组织修复. 需要标准化和指导方针来克服PRP组成和应用方面的挑战,以获得更好的临床结果.
科学领域:
- 再生医学是一种再生医学.
- 生物材料是一种生物材料.
- 组织工程是组织工程.
背景情况:
- 血液是一种重要的液体组织,富含生物功能所必需的蛋白质.
- 凝血系统,包括血小板和血蛋白,在凝血,防御和组织修复中发挥关键作用.
- 富血小板血 (PRP) 模仿自然凝血和静血,作为再生疗法中生长因子的输送系统.
研究的目的:
- 探索富血小板血 (PRP) 作为一种创新的自主疗法的潜力.
- 讨论血液加工以制造PRP及其治疗特性.
- 解决围绕PRP异质性和应用的挑战和争议.
主要方法:
- 血液处理涉及抗凝固,离心裂变和血激活.
- PRP制剂的目的是集中血小板及其相关生长因子.
- 该研究审查了关于PRP制造和应用的现有文献.
主要成果:
- PRP具有抗炎性,热带性,抗纤维性和抗性质.
- 在PRP的组成和应用方法的变化导致争议和不一致的临床结果.
- 患者特定的因素,如年龄,可能会对PRP疗法的有效性产生负面影响.
结论:
- 标准化PRP制造工艺对于持续的治疗效果至关重要.
- 制定明确的PRP应用指南是必要的,以改善临床结果.
- 探索全源PRP可能为克服与自身治疗相关的局限性提供解决方案.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K


